AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....
Robbins LLP, a global investor rights law firm, is reminding stockholders of AstraZeneca PLC (AZN) about the upcoming lead plaintiff deadline in the class action lawsuit against the company....
Pathstone Holdings LLC has announced its intention to acquire AstraZeneca PLC, a leading pharmaceutical company specializing in immunotherapy....
AstraZeneca PLC, a multinational pharmaceutical company, is facing an investigation in China regarding the actions of its president....
AstraZeneca PLC (NASDAQ: AZN) has recently witnessed a significant acquisition of shares by Hilltop Holdings Inc....
Monster Beverage Corporation, a leading energy drink manufacturer, has recommended its stockholders to reject a recent mini-tender offer proposed by TRC Capital Investment Corporation....